ifosfamide has been researched along with Cystadenocarcinoma, Serous in 5 studies
Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this retrospective study was to evaluate the activity and toxicity of bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer." | 1.40 | Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases. ( Li, Y; Shang, YM; Yang, Y; Zheng, H, 2014) |
| "Patients with stage I ovarian cancer show a high incidence of recurrent disease ranging from 30% to 50%, which may be associated with a shortened survival." | 1.31 | The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma. ( Aydiner, A; Bengisu, E; Berkman, S; Eralp, Y; Saip, P; Saliho, Y; Salihoğlu, Y; Taş, F; Topuz, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sueoka, K | 1 |
| Umayahara, K | 1 |
| Abe, A | 1 |
| Usami, T | 1 |
| Yamamoto, A | 1 |
| Nomura, H | 1 |
| Matoda, M | 1 |
| Okamoto, S | 1 |
| Omatsu, K | 1 |
| Kondo, E | 1 |
| Kato, K | 1 |
| Takeshima, N | 1 |
| Li, Y | 1 |
| Yang, Y | 1 |
| Shang, YM | 1 |
| Zheng, H | 1 |
| Zylberberg, B | 1 |
| Dormont, D | 1 |
| Madelenat, P | 1 |
| Daraï, E | 1 |
| Fruscio, R | 1 |
| Colombo, N | 1 |
| Lissoni, AA | 1 |
| Garbi, A | 1 |
| Fossati, R | 1 |
| Ieda', N | 1 |
| Torri, V | 1 |
| Mangioni, C | 1 |
| Topuz, E | 1 |
| Eralp, Y | 1 |
| Saip, P | 1 |
| Aydiner, A | 1 |
| Taş, F | 1 |
| Saliho, Y | 1 |
| Salihoğlu, Y | 1 |
| Berkman, S | 1 |
| Bengisu, E | 1 |
2 trials available for ifosfamide and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Ca | 2004 |
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemother | 2008 |
3 other studies available for ifosfamide and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin | 2015 |
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined C | 2014 |
The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2001 |